[1 (+) ornithine alpha ketoglutarate in hepatic encephalopathy].
D001927:Brain Diseases / Q000188:drug therapy* / Q000209:etiology; D004569:Electroencephalography; D006501:Hepatic Encephalopathy / Q000188:drug therapy; D006505:Hepatitis / Q000150:complications; D006801:Humans; D007656:Ketoglutaric Acids / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000150:complications; D008107:Liver Diseases / Q000150:complications* / Q000188:drug therapy*; D008113:Liver Neoplasms / Q000150:complications; D009952:Ornithine / Q000627:therapeutic use*
D007656:Ketoglutaric Acids; D009952:Ornithine
L'alpha-cétoglutarate de 1 (+) ornithine dans les encéphalopathies des hépatiques.